Return
Multiple Myeloma, Version 3.2021
DOI:10.6004/jnccn.2020.0057.png)
Abstract
En 中文
Multiple myeloma is a malignant neoplasm of plasma cells that accumulate in bone marrow, leading to bone destruction and marrow failure. This manuscript discusses the management of patients with solitary plasmacytoma, smoldering multiple myeloma, and newly diagnosed multiple myeloma.
Keywords:
STEM-CELL TRANSPLANTATION
DONOR LYMPHOCYTE INFUSIONS
HIGH-DOSE THERAPY
TERM-FOLLOW-UP
LENALIDOMIDE PLUS DEXAMETHASONE
MULTIPARAMETER FLOW-CYTOMETRY
INTERNATIONAL STAGING SYSTEM
SINGLE-CENTER EXPERIENCE
NEWLY-DIAGNOSED MYELOMA
RANDOMIZED PHASE-III
Journal
J
IF:
16.4
Papers:
2.8K
Citations:
1.5W



